Top Recruiting Trials
20 actively recruiting studies
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
University Hospitals Cleveland Medical Center
n=16
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Intervention OTHER: Community Health Worker — Community Health Worker will meet with families monthly (and more often as needed) in the role of a diabetes technology ...
Eligibility Ages 5 Years – 17 Years
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
Gilles Boire
n=1000
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec
Eligibility Ages 18 Years – 90 Years
Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
Seoul National University Hospital
n=126
Seoul National University Hospital
Seoul
Intervention DEVICE: FreeStyle Libre — Flash glucose monitoring + Education on lifestyle modification
Eligibility Ages 19 Years – 80 Years
Pocket-X Gel Non-surgical Periodontal Therapy
Universita di Verona
n=70
Alessia Pardo 3494628471 Alessia.pardo@univr.it
Verona, Italy
Intervention DEVICE: Gel therapy after non surgical therapy — The gel in use is a composition of Hyaluronic acid, Poloxamer, 2-Phenoxyethanol, Octedine HCL,Water (Pocket-X Gel Geistl...
Eligibility Ages 18 Years – 80 Years
Research Accelerated by You Lupus Registry
Lupus Foundation of America
n=10000
Online Registry - No Physical Site Required
Washington D.C., District of Columbia
Incidence and Clinical Features of Breakthrough Pain After Brachial Plexus Block in Diabetic Patients
Second Hospital of Shanxi Medical University
n=216
Second Hospital of Shanxi Medical University
Taiyuan
Eligibility Ages 18 Years – 80 Years
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Children's National Research Institute
n=90
Children's National Health System
Washington D.C., District of Columbia
Intervention OTHER: No Intervention — No Intervention
Eligibility Ages 5 Years – 21 Years
UK Islet Autoantibody Registry
University of Oxford
n=350
University of Oxford
Oxford, Oxfordshire
Eligibility Ages 6 Months – 70 Years
Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders
University Hospital, Grenoble
n=100
Grenoble
Grenoble
Eligibility Ages 18 Years
A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Hinge Bio
n=30
Investigational site
Brisbane
Intervention DRUG: HB2198 — HB2198, a Tetravalent Bispecific Anti-CD19/CD20 Antibody with Dual Fc Domains
Eligibility Ages 18 Years – 65 Years
Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
n=3000
Xinyang Central Hospital
Xinyang, Henan
Eligibility Ages 18 Years
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Medical College of Wisconsin
n=20
Medical College of Wisconsin
Milwaukee, Wisconsin
Intervention DIETARY_SUPPLEMENT: Cherry Sports Drink — 12 oz bottle (1 1/2 cups) of Gatorade G Zero Glacier Cherry™ Sports Drink
Eligibility Ages 15 Years – 24 Years
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
University of Leicester
n=593
University of Leicester
Leicester
Intervention DIAGNOSTIC_TEST: Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy — CMR scanning performed on a 3T MRI scanner. Standardised protocol incorporating cine functional assessment to determine ...
Eligibility Ages 50 Years – 75 Years
The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register
Chinese University of Hong Kong
n=1000
Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital
Hong Kong, New Territories
Intervention OTHER: No intervention (observational study) — There is no intervention involved in this observational study.
Eligibility Ages 18 Years
Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
Assistance Publique - Hôpitaux de Paris
n=400
Service de Rhumatologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris
Boulogne-Billancourt
Intervention BIOLOGICAL: Faecal sampling — Faecal sampling at baseline
Eligibility Ages 18 Years
Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
University of Copenhagen
n=460
GP practices
Copenhagen, Capital Region
Intervention OTHER: focus on vision impairment in older patients in general practice — GP or GP nurse carry out the three vision tests. All patients visit optician shop collaborating with the project. An oph...
Eligibility Ages 70 Years
Think-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes
Marmara University
n=40
Marmara University
Istanbul
Intervention OTHER: Insulin Self-Management Know-Find-Solve Activity Book — The Insulin Self-Management Find-Search-Solve Activity Book was developed based on national and international literature...
Eligibility Ages 8 Years – 12 Years
Continuous Glucose Monitoring Glycemic cHAracterization During Pregnancy
KK Women's and Children's Hospital
n=60
KK Women's and Children's Hospital
Singapore, Singapore
Intervention DEVICE: Continuous glucose monitoring — Continuous glucose monitoring sensor: All study participants wear the sensor on the back of either right or left upper a...
Eligibility Ages 21 Years – 45 Years, FEMALE only
Environment, Inflammation and Metabolic Diseases Study
Qifu Li
n=8000
The First Affiliated Hospital of Chongqing Medical University
Chongqing
Intervention OTHER: observe — A single observational cohort of study participants undergoing baseline biochemical screening for autonomous aldosterone...
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
The United Bio-Technology (Hengqin) Co., Ltd.
n=956
Zhongshan Hospital，Fudan University
Shanghai
Intervention DRUG: UBT251 Injection 2.0 mg group — UBT251 Injection subcutaneously once weekly
Eligibility Ages 18 Years – 75 Years